Kimberley Do

High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report

Andy Pan, Imran Khan, Marlene Mansour, Bernadett Kovacs, Caitlin Richler, Christine Landry, Kimberley Do, Sydney Morin, Deb Purkayastha, Melissa Varsava, Emma Baun & Pierre Thabet · International Journal of Medical and Pharmaceutical Case Reports · 2025

This case report highlights the use of intravenous high-dose Epoprostenol for managing severe digital ischemia in a patient diagnosed with antisynthetase syndrome (ASyS) exhibiting anti-Jo1 antibodies positivity, emphasizing its vasodilatory benefits and challenges with tolerabil...

Open access Research Article 10.9734/ijmpcr/2025/v18i1408

Ertapenem-Induced Encephalopathy: A Case Report Highlighting Carbapenem-associated Neurotoxicity

Imran Khan, Kadir Abdi, Abdillahi, Vanessa Lasalle, Marlene Mansour, Arif Ismail, Bernadett Kovacs, Kaouther Derouiche, Caitlin Richler, Christine Landry, Sydney Morin, Kimberley Do, Laurent Montpetit, Marian Shafik & Pierre Thabet · International Journal of Medical and Pharmaceutical Case Reports · 2025

Background: Ertapenem is a once-daily carbapenem antibiotic commonly used in the treatment of complicated infections. Although traditionally associated with a lower risk of central nervous system (CNS) toxicity compared to imipenem, emerging reports highlight the potential for er...

Open access Research Article 10.9734/ijmpcr/2025/v18i3443